Literature DB >> 17826835

Subclinical changes in the juvenile crystalline macular dystrophy in Sjögren-Larsson syndrome detected by optical coherence tomography.

Joris Fuijkschot1, Johannes R M Cruysberg, Michèl A A P Willemsen, Jan E E Keunen, Thomas Theelen.   

Abstract

PURPOSE: To study morphologic changes in the macula by optical coherence tomography (OCT) in patients with a crystalline macular dystrophy due to the autosomal recessive neurocutaneous Sjögren-Larsson syndrome (SLS).
DESIGN: Retrospective observational case series. PARTICIPANTS: Twenty-seven eyes of 14 patients, mean age 14.6 (range, 3-24) years, with biochemically and genetically proven SLS underwent clinical and OCT investigation between September 2004 and September 2006.
METHODS: All patients underwent full ophthalmologic examination including slit-lamp biomicroscopy and binocular ophthalmoscopy. Optical coherence tomography of all eyes was performed using the macular thickness map protocol of Stratus OCT. MAIN OUTCOME MEASURES: Macular morphology in clinical examination and OCT.
RESULTS: Beside clinically visible perimacular crystalline deposits in all eyes of all study participants, macular morphology and reflectivity were significantly changed on OCT compared with healthy eyes. We found focal hyperreflectivities in all study eyes within the perifoveal ganglion cell layer and the inner plexiform layer, corresponding to the clinical localization of retinal crystals. More interestingly, a cystoid foveal degeneration on OCT was present in the majority of patients with SLS (18/27 eyes, or 67% of all eyes studied), varying from multiple microcystoid spaces to cystoid foveal atrophy. In general, patients who were severely affected on OCT showed intense changes on previously performed cerebral magnetic resonance spectroscopy.
CONCLUSIONS: Patients with SLS show a childhood-onset crystalline macular dystrophy with cystoid foveal atrophy on OCT in most cases. The intraretinal deposition of lipid metabolites may lead to Müller cell degeneration with subsequent formation of cystoid spaces or atrophic changes within the fovea. Because this macular dystrophy is present in all examined patients with SLS, familiarity with this maculopathy seems important for the diagnosis of this rare systemic disease.

Entities:  

Mesh:

Year:  2007        PMID: 17826835     DOI: 10.1016/j.ophtha.2007.05.063

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Retinal crystals in type 2 idiopathic macular telangiectasia.

Authors:  Ferenc B Sallo; Irene Leung; Mina Chung; Ute E K Wolf-Schnurrbusch; Alfredo Dubra; David R Williams; Traci Clemons; Daniel Pauleikhoff; Alan C Bird; Tunde Peto
Journal:  Ophthalmology       Date:  2011-08-12       Impact factor: 12.079

2.  [Morphological characteristics in macular telangiectasia type 2].

Authors:  P Charbel Issa; T F C Heeren; E Krüger; M Zeimer; D Pauleikhoff; F G Holz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

3.  Segmentation of Retinal Layers in Sjögren-Larsson Syndrome.

Authors:  Loren S Jack; Christy Benson; Mohammad A Sadiq; William B Rizzo; Eyal Margalit
Journal:  Ophthalmology       Date:  2015-03-14       Impact factor: 12.079

4.  Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.

Authors:  Shaza N Al-Holou; Edward Siefker; Samiksha Fouzdar-Jain; Donny W Suh; William B Rizzo
Journal:  Ophthalmic Genet       Date:  2020-06-08       Impact factor: 1.803

5.  Optical coherence tomography aspect of crystalline macular dystrophy in Sjögren-Larsson syndrome.

Authors:  Salima Bhallil; Fouad Chraibi; Idriss Benatiya Andalloussi; Hicham Tahri
Journal:  Int Ophthalmol       Date:  2012-08-30       Impact factor: 2.031

6.  OPHTHALMIC FINDINGS IN LATE STAGE SJOGREN-LARSSON SYNDROME.

Authors:  Tavish Nanda; Jaclyn L Kovach
Journal:  Retin Cases Brief Rep       Date:  2019 Summer

Review 7.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

Review 8.  Sjögren-Larsson syndrome in clinical practice.

Authors:  Joris Fuijkschot; Thomas Theelen; Marieke M B Seyger; Marinette van der Graaf; Imelda J M de Groot; Ron A Wevers; Ronald J A Wanders; Hans R Waterham; Michèl A A P Willemsen
Journal:  J Inherit Metab Dis       Date:  2012-07-26       Impact factor: 4.982

9.  Rod-Mediated Dark Adaptation and Macular Pigment Optical Density in Older Adults with Normal Maculas.

Authors:  Anna V Zarubina; Carrie E Huisingh; Mark E Clark; Kenneth R Sloan; Gerald McGwin; Jason N Crosson; Christine A Curcio; Cynthia Owsley
Journal:  Curr Eye Res       Date:  2018-05-01       Impact factor: 2.424

10.  Sjögren-Larsson syndrome: Anesthetic considerations and practical recommendations.

Authors:  Marcellene H Franzen; Michelle M LeRiger; Kaitlyn P Pellegrino; Jane A Kugler; William B Rizzo
Journal:  Paediatr Anaesth       Date:  2020-10-26       Impact factor: 2.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.